» Articles » PMID: 29506057

Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?

Overview
Journal Clin Infect Dis
Date 2018 Mar 6
PMID 29506057
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Retention in preexposure prophylaxis (PrEP) care is critical to elimination of human immunodeficiency virus. We reviewed all Howard Brown Health patients receiving PrEP (n = 5583) from 2012 to 2017. Among those with 12 months of follow-up, 43% remained in care, yet only 15% had all 4 quarters with a PrEP visit. Insurance status and comorbid conditions were drivers of retention in care.

Citing Articles

Engagement in Preexposure Prophylaxis Care at 1 Year Among Men Who Have Sex With Men Enrolled in the French ANRS PREVENIR Cohort Study.

Liegeon G, Assoumou L, Beniguel L, Palich R, Pialoux G, Slama L Open Forum Infect Dis. 2025; 12(1):ofae744.

PMID: 39845018 PMC: 11752861. DOI: 10.1093/ofid/ofae744.


Implementation and Evaluation of a Home-Based Pre-Exposure Prophylaxis Monitoring Option: Protocol for a Randomized Controlled Trial.

Cannon C, Holzhauer K, Golden M JMIR Res Protoc. 2024; 13:e56587.

PMID: 39312771 PMC: 11459110. DOI: 10.2196/56587.


Long-Term HIV Pre-Exposure Prophylaxis Persistence and Reinitiation in Connecticut from 2012 to 2018.

Tao J, Gu M, Galarraga O, Kapadia J, Martin H, Parent H Popul Health Manag. 2024; 27(4):267-274.

PMID: 38980808 PMC: 11698670. DOI: 10.1089/pop.2024.0012.


Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users.

Martinson T, Montoya R, Moreira C, Kuncze K, Sassaman K, Heise M AIDS. 2024; 38(11):1671-1676.

PMID: 38905507 PMC: 11293961. DOI: 10.1097/QAD.0000000000003962.


Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial.

Liu A, Alleyne C, Doblecki-Lewis S, Koester K, Gonzalez R, Vinson J JMIR Form Res. 2024; 8:e54073.

PMID: 38536232 PMC: 11007601. DOI: 10.2196/54073.


References
1.
Volk J, Marcus J, Phengrasamy T, Blechinger D, Nguyen D, Follansbee S . No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015; 61(10):1601-3. PMC: 4809999. DOI: 10.1093/cid/civ778. View

2.
Marks S, Merchant R, Clark M, Liu T, Rosenberger J, Bauermeister J . Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men. AIDS Patient Care STDS. 2017; 31(11):470-478. PMC: 5665093. DOI: 10.1089/apc.2017.0171. View

3.
Cohen S, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle B, Feaster D . High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2014; 68(4):439-48. PMC: 4334721. DOI: 10.1097/QAI.0000000000000479. View

4.
McNairy M, El-Sadr W . A paradigm shift: focus on the HIV prevention continuum. Clin Infect Dis. 2014; 59 Suppl 1:S12-5. PMC: 4141493. DOI: 10.1093/cid/ciu251. View

5.
Mugavero M, Westfall A, Zinski A, Davila J, Drainoni M, Gardner L . Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012; 61(5):574-80. PMC: 3508092. DOI: 10.1097/QAI.0b013e318273762f. View